NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/09/2026
Back to search
Official data from USPTO
GENFIT TOWARDS BETTER MEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
06/09/2026
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
08/29/2025
Registration date
06/09/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/09/2026
Last transaction
06/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
33
Owner location
FR
Examiner
SHERMAN, GENEVA R
Law office
O60
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a sphere with the left side in blue and the right side in orange with a blue circle in the upper part of the orange side with a straight lower edge and a stylized representation of a white DNA helix next to the blue wording "GENFIT" above the orange wording "TOWARDS BETTER MEDICINE".
Holders and representatives
Holders
GENFIT
Representatives
Ronald M. Kachmarik Cooper Legal Group LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspharmaceutical preparations for the prevention and treatment of liver diseasesmetabolic diseasesgastroenterological diseasesgastrointestinal diseasesinflammatory diseasesimmune disorders and cancer; chemical preparations for medical usefor pharmaceutical usefor the prevention and treatment of liver diseasesmetabolic diseasesgastroenterological diseasesgastrointestinal diseasesinflammatory diseasesimmune disorders and cancer; biological preparations for medical usefor pharmaceutical use for the prevention and treatment of liver diseasesmetabolic diseasesgastroenterological diseasesgastrointestinal diseasesinflammatory diseasesimmune disorders and cancer; biological preparations for use in cell cultures for medical usefor pharmaceutical use for the prevention and treatment of liver diseasesmetabolic diseasesgastroenterological diseasesgastrointestinal diseasesinflammatory diseasesimmune disorders and cancer for gene therapy and cell therapy; diagnostic and research kits for preparing cells and for selecting biologically active compounds; diagnostic products for medical or veterinary usediagnostic assay kits and reagents for medical or veterinary use; diagnostic reagents for medical or veterinary use; medical diagnostic reagents for in-vitro use in biochemistryclinical chemistry and microbiology
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/09/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/21/2026
PUBO
PUBLISHED FOR OPPOSITION
04/21/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/15/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/26/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/19/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/19/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/19/2026
RFNT
REFUSAL PROCESSED BY IB
03/05/2026
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/14/2026
RFRR
REFUSAL PROCESSED BY MPU
02/14/2026
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/17/2026
CNRT
NON-FINAL ACTION WRITTEN
01/16/2026
DOCK
ASSIGNED TO EXAMINER
01/13/2026
MAFR
APPLICATION FILING RECEIPT MAILED
11/02/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/02/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/30/2025
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
10/02/2025
Continuous trademark protection
Get notified about every new filing that threatens GENFIT TOWARDS BETTER MEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.